These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3007907)

  • 1. Identification of a ouabain-like compound in toad skin and plasma as a bufodienolide derivative.
    Lichtstein D; Kachalsky S; Deutsch J
    Life Sci; 1986 Apr; 38(14):1261-70. PubMed ID: 3007907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia.
    Lopatin DA; Ailamazian EK; Dmitrieva RI; Shpen VM; Fedorova OV; Doris PA; Bagrov AY
    J Hypertens; 1999 Aug; 17(8):1179-87. PubMed ID: 10466474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further characterisation of the inotropic effect of a bufodienolide glycoside--an endogenous ouabain like compound.
    Shimoni Y; Gotsman M; Epstein M; Kachalsky S; Deutsch J; Lichtstein D
    Cardiovasc Res; 1986 Mar; 20(3):229-39. PubMed ID: 3708656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ouabain receptor in animal tissues and its endogenous ligand.
    Lichtstein D; Samuelov S; Deutsch J; Xu H; Lutz RA; Chernick SS; Chernick SS
    Klin Wochenschr; 1987; 65 Suppl 8():40-8. PubMed ID: 3037184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bufadienolides from parotoid gland secretions of Cuban toad Peltophryne fustiger (Bufonidae): Inhibition of human kidney Na(+)/K(+)-ATPase activity.
    Perera Córdova WH; Leitão SG; Cunha-Filho G; Bosch RA; Alonso IP; Pereda-Miranda R; Gervou R; Touza NA; Quintas LE; Noël F
    Toxicon; 2016 Feb; 110():27-34. PubMed ID: 26615828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous ouabain-like compound increases heart muscle contractility.
    Shimoni Y; Gotsman M; Deutsch J; Kachalsky S; Lichtstein D
    Nature; 1984 Jan 26-Feb 1; 307(5949):369-71. PubMed ID: 6320001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marinoic acid, a novel bufadienolide-related substance in the skin of the giant toad, Bufo marinus.
    Matsukawa M; Akizawa T; Morris JF; Butler VP; Yoshioka M
    Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):255-7. PubMed ID: 8582043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous marinobufagenin-like factor in acute plasma volume expansion.
    Fedorova OV; Doris PA; Bagrov AY
    Clin Exp Hypertens; 1998; 20(5-6):581-91. PubMed ID: 9682914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digitalis-like compounds in the toad Bufo viridis: interactions with plasma proteins.
    Lichtstein D; Gati I; Ovadia H
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S102-5. PubMed ID: 7508011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma marinobufagenin-like and ouabain-like immunoreactivity in adrenocorticotropin-treated rats.
    Fedorova OV; Anderson DE; Bagrov AY
    Am J Hypertens; 1998 Jul; 11(7):796-802. PubMed ID: 9683040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of a ouabain-like compound from human plasma.
    Hamlyn JM; Blaustein MP; Bova S; DuCharme DW; Harris DW; Mandel F; Mathews WR; Ludens JH
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6259-63. PubMed ID: 1648735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of an endogenous Na+,K(+)-ATPase-specific inhibitor from pig urine.
    Tamura M; Harris TM; Konishi F; Inagami T
    Eur J Biochem; 1993 Jan; 211(1-2):317-27. PubMed ID: 8381085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma potassium may protect sodium pumps of toad hearts from an endogenous inhibitor.
    Else PL
    Am J Physiol; 1994 Sep; 267(3 Pt 2):R754-61. PubMed ID: 8092319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of a bufodienolide and ouabain on neuronal and smooth muscle preparations.
    Oberfrank F; Vizi ES; Baker PF; Samuelov S; Lichtstein D
    Neurosci Res; 1991 May; 10(4):235-44. PubMed ID: 1652719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of 11,13-dihydroxy-14-octadecaenoic acid as a circulating Na+/K(+)-ATPase inhibitor.
    Lichtstein D; Samuelov S; Gati I; Felix AM; Gabriel TF; Deutsch J
    J Endocrinol; 1991 Jan; 128(1):71-8. PubMed ID: 1847965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two biologically active isomers of dihydroouabain isolated from a commercial preparation.
    Qazzaz HM; El-Masri MA; Stolowich NJ; Valdes R
    Biochim Biophys Acta; 1999 Nov; 1472(3):486-97. PubMed ID: 10564763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of three sodium-potassium adenosine triphosphatase inhibitors.
    Pamnani MB; Chen S; Bryant HJ; Schooley JF; Eliades DC; Yuan CM; Haddy FJ
    Hypertension; 1991 Sep; 18(3):316-24. PubMed ID: 1653768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel bufadienolide, marinosin, in the skin of the giant toad, Bufo marinus.
    Matsukawa M; Akizawa T; Ohigashi M; Morris JF; Butler VP; Yoshioka M
    Chem Pharm Bull (Tokyo); 1997 Feb; 45(2):249-54. PubMed ID: 9118440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a urinary bufodienolide Na+,K+-ATPase inhibitor in patients after acute myocardial infarction.
    Bagrov AY; Fedorova OV; Dmitrieva RI; Howald WN; Hunter AP; Kuznetsova EA; Shpen VM
    Hypertension; 1998 May; 31(5):1097-103. PubMed ID: 9576120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bufodienolide nature of endogenous inhibitor of human sodium-potassium adenosine triphosphatase].
    Dmitrieva RI; Georgiev IIu; Shpen' VM; Bagrov AIa
    Zh Evol Biokhim Fiziol; 1997; 33(3):355-63. PubMed ID: 9479394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.